Yantai BioHigh volume
Tirzepatide
spec: 5mg / 10mg / 15mg / 20mg vials
Dual GIP/GLP-1 receptor agonist. Consistently among our highest-volume research peptides.
≥99% HPLCDetails →
A synthetic triple agonist that acts on the GIP, GLP-1 and glucagon receptors. It has been our highest-demand sequence since we added it to the catalogue, driven by research into triple-agonist metabolic models. We synthesise it on our own SPPS line with Fmoc chemistry, purify by HPLC, and release it only after mass spectrometry and an outside laboratory have both signed off.
Batch RT-2026-08 · ≥99% purity · released only after independent laboratory sign-off.
Every batch is verified by an independent third-party laboratory before dispatch. A chromatogram from a recent lot is shown here.
📄 View sample COADual GIP/GLP-1 receptor agonist. Consistently among our highest-volume research peptides.
GLP-1 receptor agonist, produced continuously so stock items ship same or next day.
